Global Medical REIT Inc(GMRE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.25 | Insider Own | 8.31% | Shs Outstand | 13.4M | Perf Week | -0.5% |
| Market Cap | 0.52B | Forward P/E | 599.67 | EPS next Y | 123.08% | Insider Trans | 2.05% | Shs Float | 12.3M | Perf Month | -0.08% |
| Enterprise Value | 1.34B | PEG | - | EPS next Q | 0.07 | Inst Own | 66.23% | Short Float | 5.25% | Perf Quarter | 11.08% |
| Income | -0.00B | P/S | 3.3 | EPS this Y | -620% | Inst Trans | 2.96% | Short Ratio | 6.02 | Perf Half Y | 2.95% |
| Sales | 0.16B | P/B | 1.18 | EPS next 5Y | - | ROA | 0.2% | Short Interest | 0.65M | Perf YTD | 6.64% |
| Book/sh | 30.61 | P/C | 50.4 | EPS past 3/5Y | -60.17% -34.34% | ROE | 0.49% | 52W High | -21.36% ($45.75) | Perf Year | -14.33% |
| Cash/sh | 0.71 | P/FCF | - | Sales past 3/5Y | 12.49% 17.14% | ROIC | -0.27% | 52W Low | 23.86% ($29.05) | Perf 3Y | -29.99% |
| Dividend Est. | $3.3 (9.17%) | EV/EBITDA | 12.73 | EPS Y/Y TTM | -131.16% | Gross Margin | 43.92% | Volatility(W/M) | 3.43% 2.54% | Perf 5Y | -41.51% |
| Dividend TTM | 3.3 | EV/Sales | 8.43 | Sales Y/Y TTM | 2.73% | Oper. Margin | 29.82% | ATR (14) | 0.91 | Perf 10Y | -87.11% |
| Dividend Ex-Date | 2025/12/19 | Quick Ratio | 1.42 | EPS Q/Q | -429% | Profit Margin | -2.09% | RSI (14) | 53.94 | Recom | 1.67 |
| Dividend Gr. 3/5Y | 0.81% 0.98% | Current Ratio | 1.42 | Sales Q/Q | 4.62% | SMA20 | 0.77% ($35.71) | Beta | 1.19 | Target Price | $40.17 |
| Payout | 6829.27% | Debt/Eq | 1.5 | Earnings | 2026/2/25 | SMA50 | 2.37% ($35.15) | Rel Volume | 0.68 | Prev Close | $35.99 |
| Employees | 26 | LT Debt/Eq | 1.5 | EPS/Sales Surpr. | -381.25% -3.02% | SMA200 | 5.62% ($34.07) | Avg Volume(3M) | 0.11M | Price | $35.98 |
| IPO | 2013/6/21 | Option/Short | Yes/Yes | Trades | 1091 | Volume | 72,688 | Change | -0.03% |
🏥 Net-Lease Medical Real Estate REIT. 84 properties totaling 2.1 million square feet. 95.2% occupancy rate. 8.61% dividend yield.
Over the past 1 year, roughly in the middle
21% below its 1-year high.
Traded less than usual. That is 68% of its average volume.
GMRE keeps an operating profit but posts a net loss
Of every $100 in sales, $29.82 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -620.0% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $330. Peers typically go for $197.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -41.5%. The S&P 500 did +62% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 9.17% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 66.2%.
Tap to view numbers
It ranks #16 of 18 in the industry
Based on market cap of $524M.
FAQ
What kind of company is GMRE?
GMRE belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of GMRE?
The market cap of GMRE is approximately $524M, ranking 3,119 within its sector.
Does GMRE pay dividends?
GMRE has a dividend yield of approximately 9.17%, with an annual dividend of $3.30.
What is the 52-week high and low for GMRE?
GMRE has recorded a 52-week high of $45.75 and a low of $29.05.
